89BIO (ETNB) News Today $14.78 -0.02 (-0.10%) As of 10:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ETNB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period 89BIO (NASDAQ:ETNB) Sees Unusually-High Trading Volume - Here's What HappenedOctober 11 at 12:13 PM | marketbeat.comWeiss Ratings Reaffirms "Sell (D-)" Rating for 89BIO (NASDAQ:ETNB)October 8, 2025 | marketbeat.com89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNBOctober 6, 2025 | businesswire.com89BIO (NASDAQ:ETNB) Given Average Rating of "Moderate Buy" by BrokeragesOctober 3, 2025 | marketbeat.comAssessing 89bio (ETNB) Valuation Following a 60% Share Price RallyOctober 2, 2025 | finance.yahoo.com89BIO Sees Unusually High Options Volume (NASDAQ:ETNB)October 2, 2025 | marketbeat.com89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout DealSeptember 30, 2025 | msn.com89BIO $ETNB Shares Acquired by Voya Investment Management LLCSeptember 25, 2025 | marketbeat.com$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 89bio, Inc. (NASDAQ: ETNB)September 23, 2025 | prnewswire.comAssenagon Asset Management S.A. Has $21.32 Million Stock Position in 89BIO $ETNBSeptember 23, 2025 | marketbeat.comRBC Capital Reaffirms Their Hold Rating on 89bio (ETNB)September 22, 2025 | theglobeandmail.comRhumbline Advisers Has $1.11 Million Holdings in 89BIO $ETNBSeptember 21, 2025 | marketbeat.com89BIO (NASDAQ:ETNB) Sees Strong Trading Volume - Still a Buy?September 20, 2025 | marketbeat.comHC Wainwright Reaffirms Neutral Rating for 89BIO (NASDAQ:ETNB)September 20, 2025 | marketbeat.com89BIO (NASDAQ:ETNB) Receives Peer Perform Rating from Wolfe ResearchSeptember 20, 2025 | marketbeat.comWolfe Research Downgrades 89bio (ETNB)September 19, 2025 | msn.com89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNBSeptember 19, 2025 | businesswire.com89BIO (NASDAQ:ETNB) Hits New 52-Week High - Time to Buy?September 19, 2025 | marketbeat.comRaymond James cuts 89bio to “market perform” after Roche’s $14.50 per share dealSeptember 19, 2025 | finance.yahoo.com89Bio (ETNB) Soars 86 Percent to Historic High on $3.5-Billion Roche MergerSeptember 19, 2025 | msn.comRoche to Buy Maker of Fatty Liver Treatment 89bio for Up to $3.5 BillionSeptember 19, 2025 | msn.comRoche To Acquire 89bio For $2.4 Billion In Liver And Cardiometabolic PushSeptember 18, 2025 | benzinga.comRoche Digs Into Obesity-Tied Diseases With $3.5 Billion 89bio BuyoutSeptember 18, 2025 | msn.comRoche Digs Into Obesity-Tied Diseases With $3.5 Billion 89bio BuyoutSeptember 18, 2025 | investors.comTop 2 Health Care Stocks That May Keep You Up At Night This MonthSeptember 18, 2025 | benzinga.comETNB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 89bio, Inc. Is Fair to ShareholdersSeptember 18, 2025 | businesswire.comSwiss pharma giant Roche to buy US-listed 89bio for $2.4 bln in cashSeptember 18, 2025 | ca.investing.comHarbor Capital Advisors Inc. Decreases Holdings in 89BIO $ETNBSeptember 18, 2025 | marketbeat.comShareholder Alert: The Ademi Firm Investigates Whether 89bio, Inc. is Obtaining a Fair Price for its Public ShareholdersSeptember 18, 2025 | businesswire.comRoche to Buy 89bio for Up to $3.5 BillionSeptember 18, 2025 | wsj.comRoche to acquire liver drug developer 89bio for up to $3.5 billionSeptember 18, 2025 | reuters.com89bio to be Acquired by Roche for Up to $20.50 per Share, Totaling $3.5 Billion in Transaction ValueSeptember 18, 2025 | quiverquant.comQ89bio, Inc. Announces Agreement to be Acquired by RocheSeptember 18, 2025 | globenewswire.comA Closer Look at 89bio (ETNB) Valuation Following Recent Share Price DriftSeptember 17, 2025 | finance.yahoo.com89BIO's (ETNB) "Sell (D-)" Rating Reiterated at Weiss RatingsSeptember 17, 2025 | marketbeat.comGoldman Sachs Group Inc. Has $7.24 Million Stake in 89BIO $ETNBSeptember 16, 2025 | marketbeat.comWoodline Partners LP Purchases 305,928 Shares of 89BIO $ETNBSeptember 15, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Buys Shares of 98,848 89BIO $ETNBSeptember 15, 2025 | marketbeat.comExome Asset Management LLC Has $2.57 Million Position in 89BIO $ETNBSeptember 11, 2025 | marketbeat.com89bio, Inc. (ETNB) Presents At Cantor Global Healthcare Conference 2025 (Transcript)September 9, 2025 | seekingalpha.comInfinitum Asset Management LLC Makes New $3.64 Million Investment in 89BIO $ETNBSeptember 9, 2025 | marketbeat.com89BIO (NASDAQ:ETNB) Given Consensus Recommendation of "Buy" by BrokeragesSeptember 9, 2025 | marketbeat.comTrexquant Investment LP Makes New Investment in 89BIO $ETNBSeptember 9, 2025 | marketbeat.comResearch Analysts Offer Predictions for 89BIO Q3 EarningsSeptember 9, 2025 | marketbeat.comAlyeska Investment Group L.P. Sells 73,170 Shares of 89BIO $ETNBSeptember 8, 2025 | marketbeat.comH.C. Wainwright Backs 89bio (ETNB) with Buy RatingSeptember 8, 2025 | msn.comNewtyn Management LLC Sells 40,000 Shares of 89BIO $ETNBSeptember 7, 2025 | marketbeat.com89BIO (NASDAQ:ETNB) Receives "Buy" Rating from HC WainwrightSeptember 6, 2025 | marketbeat.comWalleye Capital LLC Has $324,000 Stock Holdings in 89BIO $ETNBSeptember 6, 2025 | marketbeat.comInvesco Ltd. Boosts Holdings in 89BIO $ETNBSeptember 6, 2025 | marketbeat.com Get 89BIO News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ETNB Media Mentions By Week ETNB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETNB News Sentiment▼0.720.75▲Average Medical News Sentiment ETNB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETNB Articles This Week▼46▲ETNB Articles Average Week Get the Latest News and Ratings for ETNB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for 89BIO and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Revolution Medicines News Merus News Avidity Biosciences News Grifols News Cytokinetics News Rhythm Pharmaceuticals News Abivax News CRISPR Therapeutics News Nuvalent News Axsome Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETNB) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredThis Crypto Is Set to Explode in JanuaryThe crypto summit Wall Street wants to stop Learn how to structure your portfolio like the top hedge funds...Crypto 101 Media | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89BIO Please log in to your account or sign up in order to add this asset to your watchlist. Share 89BIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
